TrialCancer2022

Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2).

Emanuela Palmerini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.